Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients

Patients with psoriasis are often affected by comorbidities, which largely influence treatment decisions. Here we performed conjoint analysis to assess the impact of comorbidities on preferences of patients with moderate-to-severe psoriasis for outcome (probability of 50% and 90% improvement, time u...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaarschmidt, Marthe-Lisa, Kromer, Christian, Herr, Raphael, Schmieder, Astrid, Sonntag, Diana, Goerdt, Sergij, Peitsch, Wiebke K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669171/
https://www.ncbi.nlm.nih.gov/pubmed/26633680
http://dx.doi.org/10.1371/journal.pone.0144335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669171/
https://www.ncbi.nlm.nih.gov/pubmed/26633680
http://dx.doi.org/10.1371/journal.pone.0144335

Ejemplares similares